NANOAI
DEAD

Serial Number

88647647

Owner

Essenlix Corporation

Attorney

Julian D. Gonzalez

Filing Date

Oct 9, 2019

Add to watchlist:

No watchlists yet
View on USPTO

NANOAI Trademark

Serial Number: 88647647

NANOAI is a trademark filed by Essenlix Corporation on October 9, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Essenlix Corporation (148 trademarks)

7 Foulet Dr
Princeton, CA 08540

Entity Type: 03

Trademark Details

Filing Date

October 9, 2019

Registration Date

Not Registered

Goods & Services

Veterinary diagnostic reagents and assays for testing of body fluids; Veterinary diagnostic reagents and assays for testing cells, proteins, small molecules, nucleotides, and nucleic acids; Veterinary diagnostic reagents; Diagnostic kits comprised of veterinary diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers, blood abnormalities, immune disease, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic biomarker reagents for veterinary purposes

Veterinary services; Veterinary assistance; Veterinary consultations; Veterinary counseling; Veterinary information; Healthcare services, namely, veterinary healthcare services; Diagnostic services, namely, veterinary testing for diagnostic purposes; Wellness services, namely, providing veterinary health and veterinary wellness information; Veterinary services, Veterinary assistance, veterinary consultations, veterinary counseling, veterinary information, veterinary healthcare testing in the nature of the diagnosis of diseases, veterinary diagnostic testing, and veterinary wellness information and consulting services, all in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Medical and veterinary testing services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample

Veterinary diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Veterinary devices for obtaining bodily fluid samples; Veterinary diagnostic instruments for the analysis of bodily fluids; Veterinary apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, or abnormalities, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Veterinary apparatus, devices, and instruments for wellness testing, health condition testing, and healthcare testing, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Veterinary apparatus, devices, and instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample

Providing veterinary healthcare testing services and information in the field of cancer research and disease classification

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 24, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 24, 2021 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 6, 2020 GNFN
FINAL REFUSAL E-MAILED
Aug 6, 2020 GNFR
FINAL REFUSAL WRITTEN
Aug 6, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 22, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 22, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 22, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jan 22, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jan 22, 2020 CNRT
ASSIGNED TO EXAMINER
Jan 14, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 15, 2019 NWOS
NEW APPLICATION ENTERED
Oct 12, 2019 NWAP